CoChat

How Much Do Focal Infarcts Distort White Matter Lesions and Global Cerebral Atrophy Measures?

Open access
Wang, Xin, Valdés Hernández, Maria C., Doubal, Fergus, Chappell, Francesca M., Wardlaw, Joanna M. · 2012 · Cerebrovascular Diseases

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background: White matter lesions (WML) and brain atrophy are important biomarkers in stroke and dementia. Stroke lesions, either acute or old, symptomatic or silent, are common in older people. Such stroke lesions can have similar signals to WML and cerebrospinal fluid (CSF) on magnetic resonance (MR) images, and may be classified accidentally as WML or CSF by MR image processing algorithms, distorting WML and brain atrophy volume from the true volume. We evaluated the effect that acute or old stroke lesions at baseline, and new stroke lesions occurring during follow-up, could have on measurement of WML volume, cerebral atrophy and their longitudinal progression. Methods: We used MR imaging data from patients who had originally presented with acute lacunar or minor cortical ischaemic stroke symptoms, recruited prospectively, who were scanned at baseline and about 3 years later. We measured WML and CSF volumes (ml) semi-automatically. We manually outlined the acute index stroke lesion (ISL), any old stroke lesions present at baseline, and new lesions appearing de novo during follow-up. We compared baseline and follow-up WML volume, cerebral atrophy and their longitudinal progression excluding and including the acute ISL, old and de novo stroke lesions. A non-parametric test (Wilcoxon’s signed rank test) was used to compare the effects. Results: Among 46 patients (mean age 72 years), 33 had an ISL visible on MR imaging (median volume 2.05 ml, IQR 0.88–8.88) and 7 of the 33 had old lacunes at baseline: WML volume was 8.54 ml (IQR 5.86–15.80) excluding versus 10.98 ml (IQR 6.91–24.86) including ISL (p < 0.001). At follow-up, median 39 months later (IQR 30–45), 3 patients had a de novo stroke lesion; total stroke lesion volume had decreased in 11 and increased in 22 patients: WML volume was 12.17 ml (IQR 8.54–19.86) excluding versus 14.79 ml (IQR 10.02–38.03) including total stroke lesions (p < 0.001). Including/excluding lacunes at baseline or follow-up also made small differences. Twenty-two of the 33 patients had tissue loss due to stroke lesions between baseline and follow-up, resulting in a net median brain tissue volume loss (i.e. atrophy) during follow-up of 24.49 ml (IQR 12.87–54.01) excluding versus 24.61 ml (IQR 15.54–54.04) including tissue loss due to stroke lesions (p < 0.001). Including stroke lesions in the WML volume added substantial noise, reduced statistical power, and thus increased sample size estimated for a clinical trial. Conclusions: Failure to exclude even small stroke lesions distorts WML volume, cerebral atrophy and their longitudinal progression measurements. This has important implications for design and sample size calculations for observational studies and randomised trials using WML volume, WML progression or brain atrophy as outcome measures. Improved methods of discriminating between stroke lesions and WML, and between tissue loss due to stroke lesions and true brain atrophy are required.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000343226

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Variation in WML volume at baseline, follow-up and progression due to excluding/including stroke lesions (SL, acute or old) at baseline and new lesions appearing at follow-up.
Fig. 1 Variation in WML volume at baseline, follow-up and progression due to excluding/including stroke lesions (SL, acute or old) at baseline and new lesions appearing at follow-up.CC BY-NC · PubMed Central
Fig. 2 Three slices from the same patient showing the influence of stroke lesions (SL) at baseline and new stroke lesions appearing during follow-up on WML volume measurements at baseline, follow-up and combined scans.
Fig. 2 Three slices from the same patient showing the influence of stroke lesions (SL) at baseline and new stroke lesions appearing during follow-up on WML volume measurements at baseline, follow-up and combined scans.CC BY-NC · PubMed Central
Fig. 3 Estimation of absolute and relative brain atrophy excluding and including the stroke lesions (SL).
Fig. 3 Estimation of absolute and relative brain atrophy excluding and including the stroke lesions (SL).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 31

Metadata

Authors
Wang, X., Valdés Hernández, M. C., Doubal, F., Chappell, F. M., & Wardlaw, J. M.
Affiliations
University of Edinburgh (GB)
Corresponding author
Wardlaw, Joanna M.
Venue
Cerebrovascular Diseases
Publisher
S. Karger AG
Published
2012
Volume
34
Issue
5-6
Pages
336-342
ISSN
  • 1015-9770 (ISSN-L)
  • 1421-9786
OpenAlex
W2167519590
Cited by
31
References
17
Citations by year
2025: 2 · 2024: 1 · 2022: 2 · 2019: 3 · 2018: 2 · 2017: 7 · 2016: 4 · 2015: 7 · 2014: 1 · 2013: 2
FWCI
2.09
Type
journal article
Language
en
Open access
Licence
Locations
  • Cerebrovascular Diseases (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (075611)
  • Mrs Gladys Row Fogo Charitable Trust
  • Brain Research Imaging Centre, University of Edinburgh
Topics
  • Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords
white matter lesions, brain atrophy, lacunes, stroke lesions, cerebrospinal fluid, longitudinal progression, lacunar stroke, minor ischaemic stroke, biomarkers, older adults, longitudinal MRI follow-up, white matter hyperintensities
MeSH terms
Aged, Aged, 80 and over, Atrophy, Cerebral Infarction, Dementia, Follow-Up Studies, Humans, Image Processing, Computer-Assisted, Longitudinal Studies, Magnetic Resonance Imaging, Disease Progression, Neurodegenerative Diseases, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How Much Do Focal Infarcts Distort White Matter Lesions and Global Cerebral Atrophy Measures? https://app.cochat.ai/papers/10.1159/000343226
The paper
Wang, X., Valdés Hernández, M. C., Doubal, F., Chappell, F. M., & Wardlaw, J. M. (2012). How Much Do Focal Infarcts Distort White Matter Lesions and Global Cerebral Atrophy Measures? Cerebrovascular Diseases. https://doi.org/10.1159/000343226

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.